A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells
about
A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A type I combi-targeting appro ...... mgmt)- expressing tumour cells
@en
type
label
A type I combi-targeting appro ...... mgmt)- expressing tumour cells
@en
prefLabel
A type I combi-targeting appro ...... mgmt)- expressing tumour cells
@en
P2860
P1433
P1476
A type I combi-targeting appro ...... mgmt)- expressing tumour cells
@en
P2093
Elliot Goodfellow
Zhor Senhaji Mouhri
P2860
P2888
P356
10.1186/S12885-017-3504-1
P407
P577
2017-08-11T00:00:00Z
P6179
1091167097